Your browser does not support iframes.
Multiple sclerosis is a chronic, unpredictable and progressive disease of the Central Nervous System, which is made up of the brain and spinal cord.Find out more about the disease here, including the different types of MS, what the symptoms are, who is affected, how they cope and Teva’s expertise in this area.
It can take up to 15 years to develop a new medicine, with rigorous investigations carried out along the way to monitor and improve its effectiveness and safety. But we don’t stop there – we keep monitoring medicines after they become available to patients to check there aren’t any unexpected side effects.
As Teva’s Senior Pharmacovigilance Professional, it’s Vanesa Ivetic Tkalcevic’s job to investigate cases where the unexpected does occur, find out what happened and make recommendations to help keep patients safe in the future.
Discussion highlights multiple chronic conditions as central to Universal Health Coverage
In February 2019, Peru was again hit by severe flooding, but Teva’s local distribution team was ready, thanks to some hard lessons learned during the previous storms, just two years before.
Jack de Graaf heads up Teva’s Environment, Health and Safety (EHS) function in Europe. It’s his job to make sure the firm’s many European factories, R&D sites, and offices are safe to work in. Ahead of ILO's World Day for Safety and Health at Work he talks about keeping 14,000 people safe, the potential for disaster if things go wrong… and why he feels a bit like Teva’s mother.
From her office near Paris, Daphne Gerrits oversees packaging design for Teva products worldwide. And if you think for one minute that a medicine box is just a box, then Daphne wants you to think again...
“…I realized I had spent my life largely ignorant to a privilege I had taken for granted, the privilege of receiving medical treatment when I was sick.” – Celine Pourmoradi, Volunteer, Clinic by the Bay (grantee of Enhancing Access2Care, program supported by Volunteers in Medicine, Direct Relief and Teva)
When Ethiopia began to run out of cancer medicines to treat children, a race against time began to get crucial supplies to the country.
Narrative review represents a key milestone in Teva’s efforts to address multiple chronic conditions
Explaining technical subjects in an easily-accessible manner isn’t the easiest of jobs, but it’s something the Teva team in Croatia grasped with both hands when designing a book on pharmacovigilance (PhV)1.